CEL-SCI Corp (CVM) Plans Common Stock, Warrants Offering
- Asia stocks rise, yen plumbs 34-year low as BOJ stands pat on rates
- Microsoft fiscal Q3 results top estimates as AI revolution spurs cloud growth
- Alphabet stock soars 12% to record high on Q1 earnings beat, first-ever dividend
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
- Oil prices on track to snap two-week losing streak
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
CEL-SCI Announces Proposed Public Offering of Common Stock and Warrants
December 1, 2016 4:01 PM ESTVIENNA, Va.--(BUSINESS WIRE)-- CEL-SCI Corporation (NYSE MKT: CVM) announced today that it intends to offer and sell, subject to market and other conditions shares of its common stock and warrants to purchase common stock. The securities are to be sold by CEL-SCI subject to market and other conditions in a public offering.
CEL-SCI currently intends to use the net proceeds from the offering to fund the continued development of Multikine*, LEAPS and for other general corporate purposes.
Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC, is... More